Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
19. November 2025
3 min to read

Artificial Intelligence Versus Human Expertise: ECG-Based Detection of Occlusive Myocardial Infarction After Cardiac Arrest

Overview

This single-centre study tested whether AI-based ECG analysis can detect occlusive myocardial infarction (OMI) after cardiac arrest using post-ROSC ECGs from 97 patients with subsequent coronary angiography. A dedicated deep neural network (Queen of Hearts, QoH) achieved the highest discrimination for acute coronary occlusion (AUC 0.85) and OMI (AUC 0.75), outperforming human experts, with a more balanced trade-off between sensitivity and specificity. In contrast, two large language model–based chatbots (ChatGPT and a GPT-based EKG Analyst) showed near-perfect sensitivity but almost no specificity, labelling nearly all ECGs as OMI and thus providing no meaningful diagnostic discrimination. These findings suggest that specialized ECG-trained AI, such as QoH, may serve as a useful adjunct in post-resuscitation decision-making. In contrast, general-purpose LLMs are currently unsuitable for critical ECG diagnosis.

Published in: Resuscitation
Published on: 19 November 2025

Background

Accurate electrocardiogram (ECG) interpretation after cardiac arrest is essential for identifying occlusive myocardial infarction (OMI), but post-resuscitation artifacts make this challenging. While artificial intelligence (AI) offers promising support, its diagnostic performance in this critical setting remains uncertain.

Methods

This single-centre study included 97 adult patients resuscitated from cardiac arrest (CA). Post-return of spontaneous circulation (ROSC), ECGs were evaluated by four methods: human experts (HE), a validated deep neural network (Queen of Hearts [QoH]), and two large language model (LLM)–based AI chatbots (AI-CB) – ChatGPT and EKG Analyst. The primary outcome was the AUROC for the presence and probability of OMI and acute coronary occlusion (ACO), determined by coronary angiography.

Results

For ACO (TIMI 0), QoH yielded the highest AUROC (0.846 [0.752–0.939]), followed by HE (0.735 [0.622 – 0.848]). Both AI-CB resulted in the lowest AUROC (ChatGPT: 0.456 [0.319 – 0.592]; EKG Analyst: 0.474 [0.346 – 0.603]. For OMI (TIMI 0-2 or TIMI 3 + peak-troponin), QoH again achieved the highest AUROC (0.745 [0.647 – 0.843]), followed by HE (0.635 [0.515 – 0.755]), AI-CB were lowest again (ChatGPT: 0.495 [0.376 – 0.614]; EKG Analyst: 0.626 [0.508 – 0.743]. Threshold-dependent performance metrics revealed high sensitivity (ACO: 100%; OMI: 98.36%) for both AI-CB, at the cost of minimal specificity. QoH and HE showed more even distributions of sensitivity/specificity.

Conclusion

QoH, despite operating without awareness of the CA-setting and thus likely at a relative disadvantage, and HE showed robust diagnostic accuracy. Due to undifferentiated overdiagnosis, general LLMs remain unsuitable for ECG interpretation. Domain-specific tools, such as QoH, may offer complementary value.

Artificial Intelligence Versus Human Expertise: ECG-Based Detection of Occlusive Myocardial Infarction After Cardiac Arrest
Authors: Claudio Silwanis, Johannes Eder, Alexander Fellner, Alexander Nahler, Max Groche, Hermann Blessberger, Jörg Kellermair, Anna Neunteufel, Maximilian Huss, Julian Maier, Clemens Steinwender, Thomas Lambert

Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

An AI Model for Electrocardiogram Detection of Occlusion Myocardial Infarction: A Retrospective Study to Reduce False Positive Cath Lab Activations

This single-centre retrospective study examined whether an AI-powered ECG model (PMcardio’s Queen of Hearts OMI model) can better detect acute occlusion myocardial infarction (OMI) and reduce false-positive cardiac catheterization laboratory (CCL) activations compared with traditional STEMI millimetre criteria. The authors analysed 304 consecutive STEMI pathway activations over a 2-year period at a tertiary academic centre and applied the AI model to pre-angiography 12-lead ECGs, comparing its performance against standard STEMI criteria. The AI model showed higher sensitivity (89.2% vs 68.3%), higher specificity (72.9% vs 51.7%), greater overall accuracy (82.9% vs 61.8%), and a high AUROC of 0.884 for identifying true OMI, while correctly flagging nearly three-quarters of false-positive activations as non-OMI. These findings suggest that integrating a specialized AI-ECG model into existing STEMI alert pathways could meaningfully reduce unnecessary CCL activations without compromising the detection of true occlusions.

Bifascicular Block Associated With Myocardial Infarction: A Marker of Proximal Left Anterior Descending Artery Occlusion Confirmed by the Artificial Intelligence-Based Smartphone App Queen of Hearts

This single-patient case report describes an elderly man presenting with chest pain, hypotension, and bifascicular block (BFB)—a combination of right bundle branch block (RBBB) and left anterior fascicular block (LAFB)—whose ECG showed QRS‑concordant anterior and lateral ST‑segment elevation consistent with a STEMI‑equivalent / occlusive myocardial infarction (OMI) pattern. Urgent coronary angiography revealed a long, severely calcified, near‑occlusive proximal left anterior descending (LAD) artery lesion, successfully treated with primary PCI and drug‑eluting stent implantation, achieving TIMI 3 flow. The Queen of Hearts (PMcardio) AI‑based smartphone app correctly classified the ECG as STEMI‑equivalent, identified atrial flutter and BFB, and predicted reduced left ventricular ejection fraction, later confirmed by echocardiography (EF 38%). This case underscores BFB with concordant anterior ST elevation as a high‑risk marker of proximal LAD‑culprit OMI and provides anecdotal evidence that specialized AI‑enabled ECG interpretation can support rapid, accurate decision‑making in ACS. 

Join over 100,000 healthcare professionals who are already taking advantage of AI